10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0001140859-20-000050 |
| Period End Date | 20200930 |
| Filing Date | 20201119 |
| Fiscal Year | 2020 |
| Fiscal Period | FY |
| XBRL Instance | abc-20200930_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
81 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Allowances for returns and doubtful accounts |
AllowancesForReturnsAndDoubtfulAccounts
|
$1.42B | USD | Point-in-time |
| Allowances for returns and doubtful accounts |
AllowancesForReturnsAndDoubtfulAccounts
|
$1.22B | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$4.60B | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$3.37B | USD | Point-in-time |
| Common stock, par value (usd per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, par value (usd per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Accounts receivable, less allowances for returns and doubtful accounts: 2020 $1,417,308; 2019 $1,222,906 |
AccountsReceivableNetCurrent
|
$13.85B | USD | Point-in-time |
| Accounts receivable, less allowances for returns and doubtful accounts: 2020 $1,417,308; 2019 $1,222,906 |
AccountsReceivableNetCurrent
|
$12.39B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$12.59B | USD | Point-in-time |
| Common stock, authorized (shares) |
CommonStockSharesAuthorized
|
600.00M | shares | Point-in-time |
| Common stock, authorized (shares) |
CommonStockSharesAuthorized
|
600.00M | shares | Point-in-time |
| Inventories |
InventoryNet
|
$11.06B | USD | Point-in-time |
| Right to recover asset |
ContractWithCustomerAssetGrossCurrent
|
$1.15B | USD | Point-in-time |
| Right to recover asset |
ContractWithCustomerAssetGrossCurrent
|
$1.34B | USD | Point-in-time |
| Common stock, issued (shares) |
CommonStockSharesIssued
|
285.30M | shares | Point-in-time |
| Common stock, issued (shares) |
CommonStockSharesIssued
|
287.79M | shares | Point-in-time |
| Common stock, outstanding (shares) |
CommonStockSharesOutstanding
|
204.23M | shares | Point-in-time |
| Income tax receivable (Note 5) |
IncomeTaxesReceivable
|
$5.86M | USD | Point-in-time |
| Income tax receivable (Note 5) |
IncomeTaxesReceivable
|
$488.43M | USD | Point-in-time |
| Common stock, outstanding (shares) |
CommonStockSharesOutstanding
|
206.76M | shares | Point-in-time |
| Prepaid expenses and other |
PrepaidExpenseAndOtherAssetsCurrent
|
$157.38M | USD | Point-in-time |
| Treasury stock (shares) |
TreasuryStockShares
|
78.53M | shares | Point-in-time |
| Prepaid expenses and other |
PrepaidExpenseAndOtherAssetsCurrent
|
$189.30M | USD | Point-in-time |
| Treasury stock (shares) |
TreasuryStockShares
|
83.56M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$33.06B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$28.13B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$1.48B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$1.77B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$6.71B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$6.71B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$6.66B | USD | Point-in-time |
| Other intangible assets |
IntangibleAssetsNetExcludingGoodwill
|
$1.89B | USD | Point-in-time |
| Other intangible assets |
IntangibleAssetsNetExcludingGoodwill
|
$2.29B | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
- | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
$361.64M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$779.85M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$269.07M | USD | Point-in-time |
| TOTAL ASSETS |
Assets
|
$44.27B | USD | Point-in-time |
| TOTAL ASSETS |
Assets
|
$39.17B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$31.71B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$28.39B | USD | Point-in-time |
| Accrued expenses and other |
AccruedLiabilitiesCurrent
|
$1.65B | USD | Point-in-time |
| Accrued expenses and other |
AccruedLiabilitiesCurrent
|
$1.06B | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$501.26M | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$139.01M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$29.58B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$33.85B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$4.03B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$3.62B | USD | Point-in-time |
| Long-term financing obligation (Note 1) |
FinanceObligation
|
- | USD | Point-in-time |
| Long-term financing obligation (Note 1) |
FinanceObligation
|
$320.52M | USD | Point-in-time |
| Accrued income taxes |
AccruedIncomeTaxesNoncurrent
|
$284.85M | USD | Point-in-time |
| Accrued income taxes |
AccruedIncomeTaxesNoncurrent
|
$284.07M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$686.49M | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$1.86B | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$98.81M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$472.86M | USD | Point-in-time |
| Accrued litigation liability |
LitigationReserveNoncurrent
|
- | USD | Point-in-time |
| Accrued litigation liability |
LitigationReserveNoncurrent
|
$6.20B | USD | Point-in-time |
| Commitments and contingencies (Note 14) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 14) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock, $0.01 par value authorized, issued, and outstanding: 2020 600,000,000 shares, 287,790,479 shares and 204,226,465 shares; 2019 600,000,000 shares, 285,295,170 shares and 206,760,654 shares |
CommonStockValue
|
$2.88M | USD | Point-in-time |
| Common stock, $0.01 par value authorized, issued, and outstanding: 2020 600,000,000 shares, 287,790,479 shares and 204,226,465 shares; 2019 600,000,000 shares, 285,295,170 shares and 206,760,654 shares |
CommonStockValue
|
$2.85M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$5.08B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$4.85B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$518.34M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$4.24B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-111.97M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-108.83M | USD | Point-in-time |
| Treasury stock, at cost: 2020 83,564,014 shares; 2019 78,534,516 shares |
TreasuryStockValue
|
$6.51B | USD | Point-in-time |
| Treasury stock, at cost: 2020 83,564,014 shares; 2019 78,534,516 shares |
TreasuryStockValue
|
$6.10B | USD | Point-in-time |
| Total AmerisourceBergen Corporation stockholders' (deficit) equity |
StockholdersEquity
|
$-1.02B | USD | Point-in-time |
| Total AmerisourceBergen Corporation stockholders' (deficit) equity |
StockholdersEquity
|
$2.88B | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$114.29M | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$179.29M | USD | Point-in-time |
| Total (deficit) equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$3.05B | USD | Point-in-time |
| Total (deficit) equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.99B | USD | Point-in-time |
| Total (deficit) equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-839.64M | USD | Point-in-time |
| Total (deficit) equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.06B | USD | Point-in-time |
| TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY |
LiabilitiesAndStockholdersEquity
|
$44.27B | USD | Point-in-time |
| TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY |
LiabilitiesAndStockholdersEquity
|
$39.17B | USD | Point-in-time |
Income Statement
135 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenue |
Revenues
|
$45.24B | USD | 1 Quarter |
| Revenue |
Revenues
|
$45.37B | USD | 1 Quarter |
| Revenue |
Revenues
|
$179.59B | USD | Annual |
| Revenue |
Revenues
|
$47.86B | USD | 1 Quarter |
| Revenue |
Revenues
|
$49.24B | USD | 1 Quarter |
| Revenue |
Revenues
|
$189.89B | USD | Annual |
| Revenue |
Revenues
|
$43.32B | USD | 1 Quarter |
| Revenue |
Revenues
|
$47.42B | USD | 1 Quarter |
| Revenue |
Revenues
|
$167.94B | USD | Annual |
| Revenue |
Revenues
|
$45.64B | USD | 1 Quarter |
| Revenue |
Revenues
|
$45.39B | USD | 1 Quarter |
| Cost of goods sold |
CostOfGoodsAndServicesSold
|
$163.33B | USD | Annual |
| Cost of goods sold |
CostOfGoodsAndServicesSold
|
$184.70B | USD | Annual |
| Cost of goods sold |
CostOfGoodsAndServicesSold
|
$174.45B | USD | Annual |
| Gross profit |
GrossProfit
|
$1.30B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$1.39B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$1.23B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$5.19B | USD | Annual |
| Gross profit |
GrossProfit
|
$1.23B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$1.42B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$4.61B | USD | Annual |
| Gross profit |
GrossProfit
|
$1.18B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$5.14B | USD | Annual |
| Gross profit |
GrossProfit
|
$1.35B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$1.23B | USD | 1 Quarter |
| Distribution, selling, and administrative |
SellingGeneralAndAdministrativeExpense
|
$2.66B | USD | Annual |
| Distribution, selling, and administrative |
SellingGeneralAndAdministrativeExpense
|
$2.46B | USD | Annual |
| Distribution, selling, and administrative |
SellingGeneralAndAdministrativeExpense
|
$2.77B | USD | Annual |
| Depreciation |
DepreciationNonproduction
|
$280.19M | USD | Annual |
| Depreciation |
DepreciationNonproduction
|
$294.96M | USD | Annual |
| Depreciation |
DepreciationNonproduction
|
$283.97M | USD | Annual |
| Amortization |
AmortizationOfIntangibleAssets
|
$110.88M | USD | Annual |
| Amortization |
AmortizationOfIntangibleAssets
|
$167.44M | USD | Annual |
| Amortization |
AmortizationOfIntangibleAssets
|
$181.16M | USD | Annual |
| Employee severance, litigation, and other (Note 13) |
RestructuringCharges
|
$6.81B | USD | Annual |
| Employee severance, litigation, and other (Note 13) |
RestructuringCharges
|
$330.47M | USD | Annual |
| Employee severance, litigation, and other (Note 13) |
RestructuringCharges
|
$183.52M | USD | Annual |
| Goodwill impairment |
GoodwillImpairmentLoss
|
- | USD | Annual |
| Goodwill impairment |
GoodwillImpairmentLoss
|
- | USD | Annual |
| Goodwill impairment |
GoodwillImpairmentLoss
|
$59.68M | USD | Annual |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$361.65M | USD | Annual |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$570.00M | USD | Annual |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$138.00M | USD | 1 Quarter |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | Annual |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$570.00M | USD | 1 Quarter |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$223.65M | USD | 1 Quarter |
| Impairment of PharMEDium assets (Note 1) |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Operating (loss) income |
OperatingIncomeLoss
|
$47.56M | USD | 1 Quarter |
| Operating (loss) income |
OperatingIncomeLoss
|
$406.69M | USD | 1 Quarter |
| Operating (loss) income |
OperatingIncomeLoss
|
$1.44B | USD | Annual |
| Operating (loss) income |
OperatingIncomeLoss
|
$-5.14B | USD | Annual |
| Operating (loss) income |
OperatingIncomeLoss
|
$-6.11B | USD | 1 Quarter |
| Operating (loss) income |
OperatingIncomeLoss
|
$179.84M | USD | 1 Quarter |
| Operating (loss) income |
OperatingIncomeLoss
|
$263.44M | USD | 1 Quarter |
| Operating (loss) income |
OperatingIncomeLoss
|
$404.83M | USD | 1 Quarter |
| Operating (loss) income |
OperatingIncomeLoss
|
$309.51M | USD | 1 Quarter |
| Operating (loss) income |
OperatingIncomeLoss
|
$1.11B | USD | Annual |
| Operating (loss) income |
OperatingIncomeLoss
|
$477.82M | USD | 1 Quarter |
| Other (income) loss |
NonoperatingIncomeExpense
|
$1.58M | USD | Annual |
| Other (income) loss |
NonoperatingIncomeExpense
|
$-25.47M | USD | Annual |
| Other (income) loss |
NonoperatingIncomeExpense
|
$12.95M | USD | Annual |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-174.70M | USD | Annual |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-157.77M | USD | Annual |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-137.88M | USD | Annual |
| Loss on consolidation of equity investments |
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss
|
- | USD | Annual |
| Loss on consolidation of equity investments |
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss
|
- | USD | Annual |
| Loss on consolidation of equity investments |
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss
|
$42.33M | USD | Annual |
| Loss on early retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$22.20M | USD | 1 Quarter |
| Loss on early retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-23.77M | USD | Annual |
| Loss on early retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
- | USD | Annual |
| Loss on early retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-22.18M | USD | Annual |
| (Loss) income before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$967.11M | USD | Annual |
| (Loss) income before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.18B | USD | Annual |
| (Loss) income before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-5.29B | USD | Annual |
| Income tax (benefit) expense |
IncomeTaxExpenseBenefit
|
$112.97M | USD | Annual |
| Income tax (benefit) expense |
IncomeTaxExpenseBenefit
|
$-1.89B | USD | Annual |
| Income tax (benefit) expense |
IncomeTaxExpenseBenefit
|
$-438.47M | USD | Annual |
| Income tax (benefit) expense |
IncomeTaxExpenseBenefit
|
$-37.00M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$132.31M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$854.13M | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$-3.40B | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$971.11M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$-4.84B | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$391.75M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$1.62B | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$186.57M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$28.07M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$287.27M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$302.00M | USD | 1 Quarter |
| Net (income) loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-42.51M | USD | Annual |
| Net (income) loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$9.16M | USD | Annual |
| Net (income) loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.23M | USD | Annual |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$-3.41B | USD | Annual |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$301.96M | USD | 1 Quarter |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$132.62M | USD | 1 Quarter |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$27.14M | USD | 1 Quarter |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$393.65M | USD | 1 Quarter |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$187.64M | USD | 1 Quarter |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$-4.85B | USD | 1 Quarter |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$1.66B | USD | Annual |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$960.28M | USD | 1 Quarter |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$289.44M | USD | 1 Quarter |
| Net (loss) income attributable to AmerisourceBergen Corporation |
NetIncomeLoss
|
$855.37M | USD | Annual |
| Basic (usd per share) |
EarningsPerShareBasic
|
$0.64 | USD | 1 Quarter |
| Basic (usd per share) |
EarningsPerShareBasic
|
$0.13 | USD | 1 Quarter |
| Basic (usd per share) |
EarningsPerShareBasic
|
$1.42 | USD | 1 Quarter |
| Basic (usd per share) |
EarningsPerShareBasic
|
$7.61 | USD | Annual |
| Basic (usd per share) |
EarningsPerShareBasic
|
$-16.65 | USD | Annual |
| Basic (usd per share) |
EarningsPerShareBasic
|
$-23.74 | USD | 1 Quarter |
| Basic (usd per share) |
EarningsPerShareBasic
|
$4.68 | USD | 1 Quarter |
| Basic (usd per share) |
EarningsPerShareBasic
|
$0.91 | USD | 1 Quarter |
| Basic (usd per share) |
EarningsPerShareBasic
|
$4.07 | USD | Annual |
| Basic (usd per share) |
EarningsPerShareBasic
|
$1.44 | USD | 1 Quarter |
| Basic (usd per share) |
EarningsPerShareBasic
|
$1.86 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$1.41 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$1.84 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$4.04 | USD | Annual |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$0.90 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$7.53 | USD | Annual |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$1.43 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$-23.74 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$0.13 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$-16.65 | USD | Annual |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$4.64 | USD | 1 Quarter |
| Diluted (usd per share) |
EarningsPerShareDiluted
|
$0.63 | USD | 1 Quarter |
| Basic (shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
204.78M | shares | Annual |
| Basic (shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
210.16M | shares | Annual |
| Basic (shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
217.87M | shares | Annual |
| Diluted (shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
220.34M | shares | Annual |
| Diluted (shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
211.84M | shares | Annual |
| Diluted (shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
204.78M | shares | Annual |
Cash Flow Statement
163 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net (loss) income |
ProfitLoss
|
$132.31M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$854.13M | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$-3.40B | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$971.11M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$-4.84B | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$391.75M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$1.62B | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$186.57M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$28.07M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$287.27M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$302.00M | USD | 1 Quarter |
| Depreciation, including amounts charged to cost of goods sold |
Depreciation
|
$290.74M | USD | Annual |
| Depreciation, including amounts charged to cost of goods sold |
Depreciation
|
$321.10M | USD | Annual |
| Depreciation, including amounts charged to cost of goods sold |
Depreciation
|
$318.48M | USD | Annual |
| Amortization, including amounts charged to interest expense |
AdjustmentForAmortization
|
$176.41M | USD | Annual |
| Amortization, including amounts charged to interest expense |
AdjustmentForAmortization
|
$191.63M | USD | Annual |
| Amortization, including amounts charged to interest expense |
AdjustmentForAmortization
|
$117.27M | USD | Annual |
| Provision for doubtful accounts |
ProvisionForDoubtfulAccounts
|
$11.91M | USD | Annual |
| Provision for doubtful accounts |
ProvisionForDoubtfulAccounts
|
$25.20M | USD | Annual |
| Provision for doubtful accounts |
ProvisionForDoubtfulAccounts
|
$16.66M | USD | Annual |
| (Benefit) provision for deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$28.54M | USD | Annual |
| (Benefit) provision for deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-1.54B | USD | Annual |
| (Benefit) provision for deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-795.52M | USD | Annual |
| Share-based compensation expense |
ShareBasedCompensation
|
$74.41M | USD | Annual |
| Share-based compensation expense |
ShareBasedCompensation
|
$62.32M | USD | Annual |
| Share-based compensation expense |
ShareBasedCompensation
|
$58.87M | USD | Annual |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$-3.00M | USD | 1 Quarter |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$23.90M | USD | 1 Quarter |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$67.32M | USD | Annual |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$7.42M | USD | Annual |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$-22.54M | USD | Annual |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$6.10M | USD | 1 Quarter |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$-35.80M | USD | 1 Quarter |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$-66.80M | USD | 1 Quarter |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$13.30M | USD | 1 Quarter |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$-9.90M | USD | 1 Quarter |
| LIFO expense (credit) |
InventoryLIFOReservePeriodCharge
|
$57.20M | USD | 1 Quarter |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$361.65M | USD | Annual |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$570.00M | USD | Annual |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$138.00M | USD | 1 Quarter |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | Annual |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$570.00M | USD | 1 Quarter |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
$223.65M | USD | 1 Quarter |
| Impairment of PharMEDium assets |
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
- | USD | 1 Quarter |
| Gain on sale of an equity investment |
EquityMethodInvestmentRealizedGainLossOnDisposal
|
- | USD | Annual |
| Gain on sale of an equity investment |
EquityMethodInvestmentRealizedGainLossOnDisposal
|
- | USD | Annual |
| Gain on sale of an equity investment |
EquityMethodInvestmentRealizedGainLossOnDisposal
|
$13.69M | USD | Annual |
| Goodwill impairment |
GoodwillImpairmentLoss
|
- | USD | Annual |
| Goodwill impairment |
GoodwillImpairmentLoss
|
- | USD | Annual |
| Goodwill impairment |
GoodwillImpairmentLoss
|
$59.68M | USD | Annual |
| Impairment of non-customer note receivable |
NoteReceivableImpairment
|
$30.00M | USD | Annual |
| Impairment of non-customer note receivable |
NoteReceivableImpairment
|
- | USD | Annual |
| Impairment of non-customer note receivable |
NoteReceivableImpairment
|
- | USD | Annual |
| Loss on consolidation of equity investments |
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss
|
- | USD | Annual |
| Loss on consolidation of equity investments |
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss
|
- | USD | Annual |
| Loss on consolidation of equity investments |
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss
|
$42.33M | USD | Annual |
| Loss on early retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$22.20M | USD | 1 Quarter |
| Loss on early retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-23.77M | USD | Annual |
| Loss on early retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
- | USD | Annual |
| Loss on early retirement of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-22.18M | USD | Annual |
| Other, net |
OtherNoncashIncomeExpense
|
$23.19M | USD | Annual |
| Other, net |
OtherNoncashIncomeExpense
|
$19.08M | USD | Annual |
| Other, net |
OtherNoncashIncomeExpense
|
$3.04M | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$657.77M | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$1.24B | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$1.63B | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$167.99M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$1.62B | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$4.92M | USD | Annual |
| Income tax receivable |
IncreaseDecreaseInIncomeTaxesReceivable
|
$482.57M | USD | Annual |
| Income tax receivable |
IncreaseDecreaseInIncomeTaxesReceivable
|
$-4.57M | USD | Annual |
| Income tax receivable |
IncreaseDecreaseInIncomeTaxesReceivable
|
$2.83M | USD | Annual |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$3.90M | USD | Annual |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$61.78M | USD | Annual |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-28.05M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$1.56B | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$859.04M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$3.30B | USD | Annual |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$209.90M | USD | Annual |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$-3.29M | USD | Annual |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$-13.35M | USD | Annual |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$239.69M | USD | Annual |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$-537.90M | USD | Annual |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$524.02M | USD | Annual |
| Accrued litigation liability |
IncreaseDecreaseInAccruedEstimatedLitigationLiability
|
- | USD | Annual |
| Accrued litigation liability |
IncreaseDecreaseInAccruedEstimatedLitigationLiability
|
$6.20B | USD | Annual |
| Accrued litigation liability |
IncreaseDecreaseInAccruedEstimatedLitigationLiability
|
- | USD | Annual |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-46.83M | USD | Annual |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-1.57M | USD | Annual |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-13.21M | USD | Annual |
| NET CASH PROVIDED BY OPERATING ACTIVITIES |
NetCashProvidedByUsedInOperatingActivities
|
$2.34B | USD | Annual |
| NET CASH PROVIDED BY OPERATING ACTIVITIES |
NetCashProvidedByUsedInOperatingActivities
|
$1.41B | USD | Annual |
| NET CASH PROVIDED BY OPERATING ACTIVITIES |
NetCashProvidedByUsedInOperatingActivities
|
$2.21B | USD | Annual |
| Capital expenditures |
PaymentsToAcquirePropertyPlantAndEquipment
|
$369.68M | USD | Annual |
| Capital expenditures |
PaymentsToAcquirePropertyPlantAndEquipment
|
$336.41M | USD | Annual |
| Capital expenditures |
PaymentsToAcquirePropertyPlantAndEquipment
|
$310.22M | USD | Annual |
| Cost of acquired companies, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$785.30M | USD | Annual |
| Cost of acquired companies, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$63.95M | USD | Annual |
| Cost of acquired companies, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
- | USD | Annual |
| Cost of equity investments |
PaymentsToAcquireEquityMethodInvestments
|
- | USD | Annual |
| Cost of equity investments |
PaymentsToAcquireEquityMethodInvestments
|
$56.08M | USD | Annual |
| Cost of equity investments |
PaymentsToAcquireEquityMethodInvestments
|
- | USD | Annual |
| Proceeds on sale of property and equipment |
ProceedsFromSaleOfPropertyPlantAndEquipment
|
$1.29M | USD | Annual |
| Proceeds on sale of property and equipment |
ProceedsFromSaleOfPropertyPlantAndEquipment
|
$8.10M | USD | Annual |
| Proceeds on sale of property and equipment |
ProceedsFromSaleOfPropertyPlantAndEquipment
|
$36.36M | USD | Annual |
| Other, net |
PaymentsForProceedsFromOtherInvestingActivities
|
$2.95M | USD | Annual |
| Other, net |
PaymentsForProceedsFromOtherInvestingActivities
|
$-9.52M | USD | Annual |
| Other, net |
PaymentsForProceedsFromOtherInvestingActivities
|
$-2.50M | USD | Annual |
| NET CASH USED IN INVESTING ACTIVITIES |
NetCashProvidedByUsedInInvestingActivities
|
$-1.11B | USD | Annual |
| NET CASH USED IN INVESTING ACTIVITIES |
NetCashProvidedByUsedInInvestingActivities
|
$-379.87M | USD | Annual |
| NET CASH USED IN INVESTING ACTIVITIES |
NetCashProvidedByUsedInInvestingActivities
|
$-375.83M | USD | Annual |
| Senior notes and other loan borrowings |
ProceedsFromIssuanceOfDebt
|
$1.31B | USD | Annual |
| Senior notes and other loan borrowings |
ProceedsFromIssuanceOfDebt
|
$506.95M | USD | Annual |
| Senior notes and other loan borrowings |
ProceedsFromIssuanceOfDebt
|
$599.48M | USD | Annual |
| Senior notes and other loan repayments |
RepaymentsOfLongTermDebt
|
$598.45M | USD | Annual |
| Senior notes and other loan repayments |
RepaymentsOfLongTermDebt
|
$510.86M | USD | Annual |
| Senior notes and other loan repayments |
RepaymentsOfLongTermDebt
|
$681.00M | USD | Annual |
| Borrowings under revolving and securitization credit facilities |
ProceedsFromLongTermLinesOfCredit
|
$25.13B | USD | Annual |
| Borrowings under revolving and securitization credit facilities |
ProceedsFromLongTermLinesOfCredit
|
$640.13M | USD | Annual |
| Borrowings under revolving and securitization credit facilities |
ProceedsFromLongTermLinesOfCredit
|
$116.95M | USD | Annual |
| Repayments under revolving and securitization credit facilities |
RepaymentsOfLinesOfCredit
|
$25.13B | USD | Annual |
| Repayments under revolving and securitization credit facilities |
RepaymentsOfLinesOfCredit
|
$149.98M | USD | Annual |
| Repayments under revolving and securitization credit facilities |
RepaymentsOfLinesOfCredit
|
$769.28M | USD | Annual |
| Payment of premium on early retirement of debt |
PaymentsOfDebtExtinguishmentCosts
|
- | USD | Annual |
| Payment of premium on early retirement of debt |
PaymentsOfDebtExtinguishmentCosts
|
$21.45M | USD | Annual |
| Payment of premium on early retirement of debt |
PaymentsOfDebtExtinguishmentCosts
|
$22.35M | USD | Annual |
| Payment of premium on early retirement of debt |
PaymentsOfDebtExtinguishmentCosts
|
$22.30M | USD | Point-in-time |
| Purchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$674.03M | USD | Annual |
| Purchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$420.45M | USD | Annual |
| Purchases of common stock |
PaymentsForRepurchaseOfCommonStock
|
$639.24M | USD | Annual |
| Exercises of stock options |
ProceedsFromStockOptionsExercised
|
$138.46M | USD | Annual |
| Exercises of stock options |
ProceedsFromStockOptionsExercised
|
$76.23M | USD | Annual |
| Exercises of stock options |
ProceedsFromStockOptionsExercised
|
$159.53M | USD | Annual |
| Cash dividends on common stock |
PaymentsOfDividendsCommonStock
|
$343.58M | USD | Annual |
| Cash dividends on common stock |
PaymentsOfDividendsCommonStock
|
$333.04M | USD | Annual |
| Cash dividends on common stock |
PaymentsOfDividendsCommonStock
|
$338.97M | USD | Annual |
| Profarma retail equity offering |
ProceedsFromIssuanceOfCommonStock
|
- | USD | Annual |
| Profarma retail equity offering |
ProceedsFromIssuanceOfCommonStock
|
$66.36M | USD | Annual |
| Profarma retail equity offering |
ProceedsFromIssuanceOfCommonStock
|
- | USD | Annual |
| Tax withholdings related to restricted share vesting |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$9.79M | USD | Annual |
| Tax withholdings related to restricted share vesting |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$8.25M | USD | Annual |
| Tax withholdings related to restricted share vesting |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$5.99M | USD | Annual |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-2.24M | USD | Annual |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-14.15M | USD | Annual |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-10.68M | USD | Annual |
| NET CASH USED IN FINANCING ACTIVITIES |
NetCashProvidedByUsedInFinancingActivities
|
$-603.62M | USD | Annual |
| NET CASH USED IN FINANCING ACTIVITIES |
NetCashProvidedByUsedInFinancingActivities
|
$-242.87M | USD | Annual |
| NET CASH USED IN FINANCING ACTIVITIES |
NetCashProvidedByUsedInFinancingActivities
|
$-1.09B | USD | Annual |
| INCREASE IN CASH AND CASH EQUIVALENTS |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$57.40M | USD | Annual |
| INCREASE IN CASH AND CASH EQUIVALENTS |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$881.68M | USD | Annual |
| INCREASE IN CASH AND CASH EQUIVALENTS |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$1.22B | USD | Annual |
| Cash and cash equivalents at beginning of year |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.44B | USD | Point-in-time |
| Cash and cash equivalents at beginning of year |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.49B | USD | Point-in-time |
| Cash and cash equivalents at beginning of year |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.37B | USD | Point-in-time |
| Cash and cash equivalents at beginning of year |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.60B | USD | Point-in-time |
| CASH AND CASH EQUIVALENTS AT END OF YEAR |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.44B | USD | Point-in-time |
| CASH AND CASH EQUIVALENTS AT END OF YEAR |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.49B | USD | Point-in-time |
| CASH AND CASH EQUIVALENTS AT END OF YEAR |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.37B | USD | Point-in-time |
| CASH AND CASH EQUIVALENTS AT END OF YEAR |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.60B | USD | Point-in-time |
Stockholders Equity
46 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash dividends (usd per share) |
CommonStockDividendsPerShareCashPaid
|
$1.66 | USD | Annual |
| Cash dividends (usd per share) |
CommonStockDividendsPerShareCashPaid
|
$1.52 | USD | Annual |
| Cash dividends (usd per share) |
CommonStockDividendsPerShareCashPaid
|
$1.60 | USD | Annual |
| Balance, beginning of period |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$3.05B | USD | Point-in-time |
| Balance, beginning of period |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.99B | USD | Point-in-time |
| Balance, beginning of period |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-839.64M | USD | Point-in-time |
| Balance, beginning of period |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.06B | USD | Point-in-time |
| Consolidation of variable interest entity |
StockholdersEquityChangeInReportingEntity
|
$167.97M | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$132.31M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$854.13M | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$-3.40B | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$971.11M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$-4.84B | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$391.75M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$1.62B | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$186.57M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$28.07M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$287.27M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$302.00M | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-33.23M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$8.28M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-8.95M | USD | Annual |
| Cash dividends |
DividendsCommonStockCash
|
$333.04M | USD | Annual |
| Cash dividends |
DividendsCommonStockCash
|
$338.97M | USD | Annual |
| Cash dividends |
DividendsCommonStockCash
|
$343.58M | USD | Annual |
| Exercises of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$76.23M | USD | Annual |
| Exercises of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$159.53M | USD | Annual |
| Exercises of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$138.46M | USD | Annual |
| Share-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$58.87M | USD | Annual |
| Share-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$62.32M | USD | Annual |
| Share-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$74.41M | USD | Annual |
| Common stock purchases for employee stock purchase plan |
AdjustmentsToAdditionalPaidInCapitalOther
|
$-341.00K | USD | Annual |
| Purchases of common stock |
TreasuryStockValueAcquiredCostMethod
|
$405.69M | USD | Annual |
| Purchases of common stock |
TreasuryStockValueAcquiredCostMethod
|
$664.80M | USD | Annual |
| Purchases of common stock |
TreasuryStockValueAcquiredCostMethod
|
$663.22M | USD | Annual |
| Profarma retail equity offering |
StockIssuedDuringPeriodValueNewIssues
|
$66.36M | USD | Annual |
| Employee tax withholdings related to restricted share vesting |
EmployeeTaxWithholdingsRelatedToRestrictedShareVesting
|
$8.25M | USD | Annual |
| Employee tax withholdings related to restricted share vesting |
EmployeeTaxWithholdingsRelatedToRestrictedShareVesting
|
$5.99M | USD | Annual |
| Employee tax withholdings related to restricted share vesting |
EmployeeTaxWithholdingsRelatedToRestrictedShareVesting
|
$9.79M | USD | Annual |
| Other |
ShareholdersEquityOther
|
$-422.00K | USD | Annual |
| Other |
ShareholdersEquityOther
|
$-718.00K | USD | Annual |
| Other |
ShareholdersEquityOther
|
$-2.56M | USD | Annual |
| Balance, end of period |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$3.05B | USD | Point-in-time |
| Balance, end of period |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.99B | USD | Point-in-time |
| Balance, end of period |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-839.64M | USD | Point-in-time |
| Balance, end of period |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$2.06B | USD | Point-in-time |
Comprehensive Income
32 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net (loss) income |
ProfitLoss
|
$132.31M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$854.13M | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$-3.40B | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$971.11M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$-4.84B | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$391.75M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$1.62B | USD | Annual |
| Net (loss) income |
ProfitLoss
|
$186.57M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$28.07M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$287.27M | USD | 1 Quarter |
| Net (loss) income |
ProfitLoss
|
$302.00M | USD | 1 Quarter |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-7.87M | USD | Annual |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-32.96M | USD | Annual |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-36.90M | USD | Annual |
| Loss on consolidation of equity investments |
OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIforInvestmentTransferredfromEquityMethodtoConsolidationNetofTax
|
$45.94M | USD | Annual |
| Loss on consolidation of equity investments |
OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIforInvestmentTransferredfromEquityMethodtoConsolidationNetofTax
|
- | USD | Annual |
| Loss on consolidation of equity investments |
OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIforInvestmentTransferredfromEquityMethodtoConsolidationNetofTax
|
- | USD | Annual |
| Other, net |
OtherComprehensiveIncomeOtherNetOfTax
|
$-1.07M | USD | Annual |
| Other, net |
OtherComprehensiveIncomeOtherNetOfTax
|
$-271.00K | USD | Annual |
| Other, net |
OtherComprehensiveIncomeOtherNetOfTax
|
$-756.00K | USD | Annual |
| Total other comprehensive (loss) income |
OtherComprehensiveIncomeLossNetOfTax
|
$-33.23M | USD | Annual |
| Total other comprehensive (loss) income |
OtherComprehensiveIncomeLossNetOfTax
|
$8.28M | USD | Annual |
| Total other comprehensive (loss) income |
OtherComprehensiveIncomeLossNetOfTax
|
$-8.95M | USD | Annual |
| Total comprehensive (loss) income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$820.91M | USD | Annual |
| Total comprehensive (loss) income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$-3.41B | USD | Annual |
| Total comprehensive (loss) income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$1.62B | USD | Annual |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-50.83M | USD | Annual |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-1.75M | USD | Annual |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-2.92M | USD | Annual |
| Comprehensive (loss) income attributable to AmerisourceBergen Corporation |
ComprehensiveIncomeNetOfTax
|
$822.65M | USD | Annual |
| Comprehensive (loss) income attributable to AmerisourceBergen Corporation |
ComprehensiveIncomeNetOfTax
|
$-3.41B | USD | Annual |
| Comprehensive (loss) income attributable to AmerisourceBergen Corporation |
ComprehensiveIncomeNetOfTax
|
$1.68B | USD | Annual |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.